SecBot SecBot
SECBOTREPLAY Home › Report › SLDB

SLDB · Solid Biosciences Inc

Solid Biosciences Inc. · 8-K filed Apr 10, 2026 at 16:09 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Apr 10, 2026 at 16:09 ET

Solid Biosciences Inc. announced a board seat reclassification for director Ilan Ganot, who resigned from Class III and was immediately reappointed to Class I to balance board composition. The move is procedural and does not reflect a change in leadership or strategy.

  • Ilan Ganot resigned from Class III of the Board and was reappointed to Class I effective April 10, 2026
  • The change was made to achieve equal balance among the three board classes
  • No changes to Ganot's compensation or role responsibilities were made
  • Stockholders will be asked to ratify the appointment on an advisory basis at the 2026 Annual Meeting

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access